Prevalence and seroprevalence of Plasmodium infection in Myanmar reveals highly heterogeneous transmission and a large hidden reservoir of infection.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
04
01
2021
accepted:
25
05
2021
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
16
11
2021
Statut:
epublish
Résumé
Malaria incidence in Myanmar has significantly reduced over recent years, however, completeness and timeliness of incidence data remain a challenge. The first ever nationwide malaria infection and seroprevalence survey was conducted in Myanmar in 2015 to better understand malaria epidemiology and highlight gaps in Annual Parasite Index (API) data. The survey was a cross-sectional two-stage stratified cluster-randomised household survey conducted from July-October 2015. Blood samples were collected from household members for ultra-sensitive PCR and serology testing for P. falciparum and P. vivax. Data was gathered on demography and a priori risk factors of participants. Data was analysed nationally and within each of four domains defined by API data. Prevalence and seroprevalence of malaria were 0.74% and 16.01% nationwide, respectively. Prevalent infection was primarily asymptomatic P. vivax, while P. falciparum was predominant in serology. There was large heterogeneity between villages and by domain. At the township level, API showed moderate correlation with P. falciparum seroprevalence. Risk factors for infection included socioeconomic status, domain, and household ownership of nets. Three K13 P. falciparum mutants were found in highly prevalent villages. There results highlight high heterogeneity of both P. falciparum and P. vivax transmission between villages, accentuated by a large hidden reservoir of asymptomatic P. vivax infection not captured by incidence data, and representing challenges for malaria elimination. Village-level surveillance and stratification to guide interventions to suit local context and targeting of transmission foci with evidence of drug resistance would aid elimination efforts.
Identifiants
pubmed: 34106995
doi: 10.1371/journal.pone.0252957
pii: PONE-D-21-00216
pmc: PMC8189444
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0252957Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Malar J. 2016 Oct 18;15(1):503
pubmed: 27756394
Am J Trop Med Hyg. 2015 Jun;92(6):1202-6
pubmed: 25918205
Adv Parasitol. 2014;84:151-208
pubmed: 24480314
J Infect Dis. 2007 Apr 1;195(7):927-33
pubmed: 17330781
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5108-13
pubmed: 15792998
PLoS One. 2010 Feb 04;5(2):e9047
pubmed: 20140220
Malar J. 2006 Feb 21;5:15
pubmed: 16504027
Southeast Asian J Trop Med Public Health. 2013;44 Suppl 1:73-165; discussion 306-7
pubmed: 24159831
Am J Trop Med Hyg. 2007 Jun;76(6):997-1008
pubmed: 17556601
Malar J. 2015 Dec 23;14:520
pubmed: 26701778
Bull World Health Organ. 1987;65(6):869-77
pubmed: 3325185
Nat Commun. 2012;3:1237
pubmed: 23212366
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4438-47
pubmed: 26216993
J Infect Dis. 2016 May 1;213(9):1491-4
pubmed: 26667316
Malar J. 2014 Nov 03;13:418
pubmed: 25363455
Int J Parasitol. 2017 Feb;47(2-3):163-170
pubmed: 28043858
PLoS One. 2011;6(9):e25137
pubmed: 21980386
PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005888
pubmed: 28892517
PLoS Negl Trop Dis. 2017 Jan 24;11(1):e0005323
pubmed: 28118367
Malar J. 2008 Sep 30;7:195
pubmed: 18826573
Trends Parasitol. 2014 Apr;30(4):183-90
pubmed: 24642035
Southeast Asian J Trop Med Public Health. 2013;44 Suppl 1:166-200; discussion 306-7
pubmed: 24159832
Nature. 2015 Dec 3;528(7580):S94-101
pubmed: 26633771
Trends Parasitol. 2007 Dec;23(12):575-82
pubmed: 17988945
PLoS Med. 2017 Feb 7;14(2):e1002224
pubmed: 28170391
Lancet Infect Dis. 2015 Apr;15(4):415-21
pubmed: 25704894
Malar J. 2017 Sep 18;16(1):377
pubmed: 28923054
Malar J. 2013 Oct 11;12:364
pubmed: 24119994